These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 24305422)

  • 1. Dyspigmentation, skin physiology, and a novel approach to skin lightening.
    Draelos Z; Dahl A; Yatskayer M; Chen N; Krol Y; Oresajo C
    J Cosmet Dermatol; 2013 Dec; 12(4):247-53. PubMed ID: 24305422
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A method for maintaining the clinical results of 4% hydroquinone and 0.025% tretinoin with a cosmeceutical formulation.
    Draelos ZD; Raab S; Yatskayer M; Chen N; Krol Y; Oresajo C
    J Drugs Dermatol; 2015 Apr; 14(4):386-90. PubMed ID: 25844613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evaluation of a kojic acid, emblica extract, and glycolic acid formulation compared with hydroquinone 4% for skin lightening.
    Draelos ZD; Yatskayer M; Bhushan P; Pillai S; Oresajo C
    Cutis; 2010 Sep; 86(3):153-8. PubMed ID: 21049734
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tolerance and efficacy of a product containing ellagic and salicylic acids in reducing hyperpigmentation and dark spots in comparison with 4% hydroquinone.
    Dahl A; Yatskayer M; Raab S; Oresajo C
    J Drugs Dermatol; 2013 Jan; 12(1):52-8. PubMed ID: 23377328
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A split-face evaluation of a novel pigment-lightening agent compared with no treatment and hydroquinone.
    Draelos ZD
    J Am Acad Dermatol; 2015 Jan; 72(1):105-7. PubMed ID: 25440437
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel approach to the treatment of hyperpigmented photodamaged skin: 4% hydroquinone/0.3% retinol versus tretinoin 0.05% emollient cream.
    Draelos ZD
    Dermatol Surg; 2005 Jul; 31(7 Pt 2):799-804. PubMed ID: 16029670
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigator-Blinded, Single-Center Study to Evaluate the Efficacy and Tolerability of a 4% Hydroquinone Skin Care System Plus 0.02% Tretinoin Cream in Mild-to-Moderate Melasma and Photodamage.
    Rendon M; Dryer L
    J Drugs Dermatol; 2016 Apr; 15(4):466-75. PubMed ID: 27050702
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A randomized and placebo-controlled study to compare the skin-lightening efficacy and safety of lignin peroxidase cream vs. 2% hydroquinone cream.
    Mauricio T; Karmon Y; Khaiat A
    J Cosmet Dermatol; 2011 Dec; 10(4):253-9. PubMed ID: 22151932
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of a skin-lightening cream targeting melanogenesis on multiple levels to triple combination cream for melasma.
    Monheit GD; Dreher F
    J Drugs Dermatol; 2013 Mar; 12(3):270-4. PubMed ID: 23545908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy of hydroquinone-free skin-lightening cream for photoaging.
    Dreher F; Draelos ZD; Gold MH; Goldman MP; Fabi SG; Puissegur Lupo ML
    J Cosmet Dermatol; 2013 Mar; 12(1):12-7. PubMed ID: 23438137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The clinical benefit of a multimodal topical approach to treating skin dyspigmentation.
    Draelos ZD; Diaz I
    J Cosmet Dermatol; 2023 Jun; 22(6):1799-1804. PubMed ID: 37102219
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of a hydroquinone-free skin brightening product using in vitro inhibition of melanogenesis and clinical reduction of ultraviolet-induced hyperpigmentation.
    Makino ET; Mehta RC; Banga A; Jain P; Sigler ML; Sonti S
    J Drugs Dermatol; 2013 Mar; 12(3):s16-20. PubMed ID: 23545928
    [TBL] [Abstract][Full Text] [Related]  

  • 13. An effective hydroquinone alternative for topical skin lightening.
    Draelos ZD; Deliencourt-Godefroy G; Lopes L
    J Cosmet Dermatol; 2020 Dec; 19(12):3258-3261. PubMed ID: 33098161
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double-blind, placebo-controlled randomized trial of Serratulae quinquefoliae folium, a new source of β-arbutin, in selected skin hyperpigmentations.
    Morag M; Nawrot J; Siatkowski I; Adamski Z; Fedorowicz T; Dawid-Pac R; Urbanska M; Nowak G
    J Cosmet Dermatol; 2015 Sep; 14(3):185-90. PubMed ID: 26119285
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treating epidermal melasma with a 4% hydroquinone skin care system plus tretinoin cream 0.025%.
    Grimes P; Watson J
    Cutis; 2013 Jan; 91(1):47-54. PubMed ID: 23461059
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prospective, randomized, double-blind clinical study of split-body comparison of topical hydroquinone and hexylresorcinol for skin pigment appearance.
    Wu H; Gabriel TA; Burney WA; Chambers CJ; Pan A; Sivamani RK
    Arch Dermatol Res; 2023 Jul; 315(5):1207-1214. PubMed ID: 36502500
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical tretinoin for treatment of photodamaged skin. A multicenter study.
    Weinstein GD; Nigra TP; Pochi PE; Savin RC; Allan A; Benik K; Jeffes E; Lufrano L; Thorne EG
    Arch Dermatol; 1991 May; 127(5):659-65. PubMed ID: 2024983
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single blind, randomized, controlled trial of a lightening product with and without iontophoresis versus tretinoin and vehicle for hyperpigmentation.
    Wanner M; Houston N; Javorsky E; Yuan M; Alora-Palli M; Kimball AB
    J Drugs Dermatol; 2015 Jan; 14(1):13-8. PubMed ID: 25607903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An efficacy study of 3 commercially available hydroquinone 4% treatments for melasma.
    Grimes PE
    Cutis; 2007 Dec; 80(6):497-502. PubMed ID: 18246882
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Continuous therapy followed by a maintenance therapy regimen with a triple combination cream for melasma.
    Grimes PE; Bhawan J; Guevara IL; Colón LE; Johnson LA; Gottschalk RW; Pandya AG
    J Am Acad Dermatol; 2010 Jun; 62(6):962-7. PubMed ID: 20398959
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.